Cost, accessibility remain issues for homebased monitoring of AMD

LISBON, Portugal — Daily home-based monitoring of age-related macular degeneration can have a positive impact on prompt, early treatment and preservation of vision, but access and cost may be issues, speakers said during a debate at the Controversies in Ophthalmology meeting. Susan B. Bressler, MD, PhD, presented results of the National Eye Institute’s HOME study, a secondary study to AREDS2, in which the ForeseeHome AMD Monitoring Program (Notal Vision) was used. The study was a 3-year phase 3 trial in which 1,520 participants were randomized 1:1 into the device group (Read more...)